Hi everyone.
On 11/11/2022, our system had provided a few picks and the results are as below:
LTHM – (Buy) – Withdrawn
ENPH – (Buy) – Profit
TEVA – (Sell) – Profit
US equities closed Friday session higher after a choppy morning session, extending Thursday’s sharp gains prompted by weaker-than-expected CPI reading for October which reinforced the case for only a modest 50 bps hike in December. The S&P 500 closed up 1%, bringing the weekly gain to 5.9%, the strongest since June. The Nasdaq 100 rose 1.9%, closing the week almost 9% higher.
Let’s review our stock picks on Friday.
Call for buy for LTHM which was withdrawn but in the right direction. Our system withdrew because the price opened with a big gap above our EP before the stock moved sideways throughout the market.
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific.
Call for buy for ENPH which resulted in a profit. Our system entered the market at $310.25 and made a call to profit at $312.29. If you followed this stock and did not take the profit, you would have exited the market with a loss as the price fell to our SL.
Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services.
Call for sell for TEVA which resulted in a profit. Our system entered the market at $9.36 and made a call to profit at $9.30. If you followed this stock and did not take the profit, you would have still be in the market with a loss.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients.
Stay tuned for more of our stock picks.
Want the next pick before it's written up?
AIRESCAN's AI publishes live recommendations in the app.